- Home
- ELSE vs SYBX Comparison
ELSE vs SYBX Comparison
Compare ELSE & SYBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELSE
- SYBX
- Stock Information
- Founded
- ELSE 1968
- SYBX N/A
- Country
- ELSE United States
- SYBX United States
- Employees
- ELSE N/A
- SYBX N/A
- Industry
- ELSE Industrial Machinery/Components
- SYBX Biotechnology: Pharmaceutical Preparations
- Sector
- ELSE Industrials
- SYBX Health Care
- Exchange
- ELSE Nasdaq
- SYBX Nasdaq
- Market Cap
- ELSE 16.4M
- SYBX 16.4M
- IPO Year
- ELSE N/A
- SYBX N/A
- Fundamental
- Price
- ELSE $4.70
- SYBX $1.46
- Analyst Decision
- ELSE
- SYBX
- Analyst Count
- ELSE 0
- SYBX 0
- Target Price
- ELSE N/A
- SYBX N/A
- AVG Volume (30 Days)
- ELSE 3.8K
- SYBX 39.6K
- Earning Date
- ELSE 08-12-2025
- SYBX 08-07-2025
- Dividend Yield
- ELSE N/A
- SYBX N/A
- EPS Growth
- ELSE 105.62
- SYBX N/A
- EPS
- ELSE 0.13
- SYBX N/A
- Revenue
- ELSE $9,551,000.00
- SYBX N/A
- Revenue This Year
- ELSE N/A
- SYBX N/A
- Revenue Next Year
- ELSE N/A
- SYBX N/A
- P/E Ratio
- ELSE $38.42
- SYBX N/A
- Revenue Growth
- ELSE 8.12
- SYBX N/A
- 52 Week Low
- ELSE $3.65
- SYBX $0.90
- 52 Week High
- ELSE $5.50
- SYBX $1.96
- Technical
- Relative Strength Index (RSI)
- ELSE 50.77
- SYBX 51.71
- Support Level
- ELSE $4.56
- SYBX $1.41
- Resistance Level
- ELSE $4.84
- SYBX $1.52
- Average True Range (ATR)
- ELSE 0.10
- SYBX 0.09
- MACD
- ELSE -0.00
- SYBX 0.00
- Stochastic Oscillator
- ELSE 50.04
- SYBX 27.59
About ELSE Electro-Sensors Inc.
Electro-Sensors Inc manufactures and sells industrial production monitoring and process control systems. It manufactures a complete line of monitoring and control systems for a wide range of industrial machine applications. The systems measure machine production and operation rates, as well as regulate the speed of related machines in production processes. Its products include motor drive control, position monitors, sensor targets, signal conditioners, speed sensors, speed switches, tachometers, temperature sensors, vibration monitors, etc.
About SYBX Synlogic Inc.
Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a lead program in phenylketonuria (PKU) and homocystinuria (HCU). The company's pipeline includes therapeutics for enteric hyperoxaluria, gout, and cystinuria. Using a proprietary approach, the company engineer GI-restricted, oral medicines from well-characterized probiotics. These drug candidates target specific biological pathways, leveraging Escherichia coli Nissle 1917 for consistency and safety. Engineered to be non-colonizing and reversible, the company offer oral administration, simplifying shipping and storage. The company operates in one segment-discovery and development of Synthetic Biotics-pioneering transformative treatments for serious diseases.